OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme
Recruiting · NCT07779343 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Health Sciences, Algeria
View the official record on ClinicalTrials.gov →Interventions studied
Behavioral TreatmentSemaglutide (Wegovy) weekly injectionWeight loss
What this trial is about
The OBESIAL (Obesity Structured Intervention in Algeria) study aims to evaluate the clinical, metabolic, and organisational impact of a structured multidisciplinary obesity care pathway implemented under real-world conditions.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adults aged 18-65 years
- BMI ≥30 kg/m²
- Written informed consent obtained prior to enrolment
Exclusion criteria
- Refusal to participate or inability to adhere to follow-up procedures
- Pregnancy at enrolment
- Severe or unstable comorbidities compromising safety or participation, including:
- Recent acute cardiovascular event (\<60 days)
- Active malignancy
- Severe unstable organic disease
- Previous bariatric surgery
- Obesity pharmacotherapy within the previous 90 days
- Known contraindication to planned therapeutic options
- Severe unstable psychiatric disorders
- Genetic obesity or obesity secondary to uncontrolled endocrine disease
- Exclusion Criteria During Follow-up
- Pregnancy occurring during follow-up
- Initiation of chronic treatment associated with weight gain
Where it is running
1 location listed.
- Department of Medicine, , Mother and Child Hospital of the Army (MCHA), Algiers University Hospital, Algiers, Algeria. - Algiers, Algeria